Physician profile
James A Waler
NPI 1104894393
$775.72
in general payments reported to CMS, 2019-2025
18 companies · $129 in 2025
The $129 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $113 · 2021: $85.86 · 2022: $124 · 2023: $112 · 2024: $85.31 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $128.28 | 2019-2025 | |
| Glaxosmithkline, LLC. | $128.02 | 2021-2025 | Shingrix, Bexsero, Arexvy |
| Novo Nordisk INC | $89.64 | 2019-2024 | Rybelsus, Ozempic |
| Pfizer INC. | $85.36 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $46.75 | 2020-2022 | |
| Becton, Dickinson and Company | $40.42 | 2022-2025 | Bd Onclarity |
| Teva Pharmaceuticals USA, INC. | $38.02 | 2019-2020 | |
| Amarin Pharma, INC. | $36.27 | 2020-2021 | |
| Ironshore Pharmaceuticals INC. | $26.14 | 2019 | |
| Genentech USA, INC. | $24.14 | 2020 | |
| Abbvie INC. | $19.12 | 2025 | |
| Cranial Technologies, INC | $17.93 | 2022 | |
| Lilly USA, LLC | $17.48 | 2023 | Trulicity, Mounjaro |
| Supernus Pharmaceuticals, INC. | $17.14 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $16.69 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $16.23 | 2023 | Myrbetriq |
| Endo Pharmaceuticals INC. | $14.72 | 2020 | |
| Hologic Sales and Service, LLC | $13.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Waler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.